Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
accidentally put in market order and the MM fleeced my badly 6000 shares they pushed itup from 3.24 to 3.38 - absolute fers - quicker we get off here the better - such crimials
Leo should insure that ASPIRE are NOT allowed to engage in short selling activities. Its an old corporate finance trick to short the be-jesus out of a stock that you know you will do equity fundings for
sure leo - is keeping the news ready for realising after we hot the nasdaq - otherwise the short sells take advantage. that's exactly what id do - hold off until we have uplisted then surprise the market with news in succession
She is clearly not a smart women why stop something that's has clearly had a positive impact on a death sentence. The mind boggles no disrespect but when people are terminal they lose all sense of logic she is still eating crap loads of carbs and living a high inflammatory diet not understanding the root cause of cancers.
Sorry if this sounds harsh but its true
Can't hear jack
adi2 yes i can't disagree with that statement - mgmt do feather their nests via salary to hedge their investment loses. Sods
Authorised shares has little to do with float. Mgmt would not be buying stock if they were about to dilute it exponentially. Seriously some people
Patty cox recently suggested that antabloc is temporarily unavailable my assumption is it will be available overseas soon. An OTC product is what we all need not a FDA approved drug under prescription for a limited aliment
We have 220 million shares in the float not a billion where did the billion come from
Have they decided on which path and condition they are going to submit NO THEY HAVENT how much more time do they need FFS this stock is run by retards
Agora newsletter writer just posted buy alert that's why. Playing fda efficacy mandate changing in 2015
Any reason why they are not trying to sell antabloc outside US does anyone know?
Not sure if that was an amazing news release - i think it showed potential but in no way did it apppear to over deliver and exceed expections that was my take. Although I'm not pharma data savy.
lauguage didn't make any waves - was to flakey
These preliminary findings suggest that patients who respond to intratumoral pIL-12 EP may have improved survival. Although caution must be exercised in interpreting the OS data, these results warrant further investigation.”
Can someone kindly post link to ellaruths latest writeup
How come the so proclaimed contracts with O&G shale plays - did not appear in the September P&L? With the price of O&G you would expect that the shale plays will be bettering down. I heard that most of the shale gales was financed with debt which they will be unable to roll if oil keeps plumetting due to lack of demand. This could get very spicy quickly.
What about the hospital & health market, IEVM claims that their product is cheaper and more effective surely clients would be lining up to cut costs.
Oh well we will have to wait and see
Forgot to add - how clever are these guys - they kept screwing foreign customers on rediculious overseas frieght charges. Why can't they just keep selling anatabloc to overseas customers only - there are plenty of foriegn. Just cause the FDA says you can't sell to US customers - so what theres a bigger market that the US.
What happened to the ecig liquids - i mean come on - all they had to do was approach the top 5 ecig liquid companies. they would be poking each others eyes out to have a deferentiating product that is good for your wellbeing. And what about the latest carcenogenic free tobacco. How much capital would it take to open up a company that makes healthy cigs - but these morons don't want to tarnish they image and be in both pharma and tobacco. Tobacco will pay the bills quickly split the company out into another vehicle - whatever JUST DO SOMETHING, than the pace your are moving now.
Ap;ogises all I am really p#ssed and had enough of this company
I am glad mullen is not CEO because he couldn't decide on what to fricken do. 18 months and nothing - he could not make a decision if he tried. Scientists will never be able to run a company - they can only run labs. Broad generalisation but a lot of truth in it. So star what are you going to submitt anatabine to the FDA for? its been close to 18 months since they said they were working on it - yet they are out of cash stock is plummeting and has killed their access to private placements. you can't sell anatabloc - all in all this goose is cooked. I blame the patent lawyer that drafted the worthless tobacco curing patents. We were far to over valued with that case and johnny was making hay at that time feeding at the troff, going a little crazy bribing governers and diluting the be jesus out of the company. Anatabloc sales via GNC did not really take off in hindsite. Its a real shame that because there is a lot of potential and big pharma will pick up the patents for pennys on the dollar. Maybe that was always the plan because they have always had a large naked short position circling them at all times.
No quarterly update marvellous
So is it true that Punit stated that he aims to release 8 deliverables by year end?
Seriously any ideas of dates for next update
Shut zee fook up everybody we have a transformational company that IS curing all forms of cancer and virus. It requires some patience just keep looking at the science and the test results it's no brainer investment give it 2-3 years we are looking at 3000 dollars a share
it was my understanding that for the K cohort they were also including people with late stage cancers - so we should very much see some efficacy data. Fingers crosses that the cohort 9-10 actually puts these later stage cancer patients into remission. Thats would be the abosolute perfect data - within p21 and p53 activation
very excited about K
I must say it is bizarre that mgmt would accumulate recently enlight of the fact that they would be aware a reverse split was in the cards I surely wouldn't be buying that's for sure.
Bizarre stock with incredible potential however would love to ask Patrick cox face to face if he still believes this is the one company to buy and hold ha ha! Looking back patty cox is good with explaining science but the a terrible stock pick and timer 95% of his picks are down 98% he needs to change his approach. He has lost a lot of money for some honest people.
anyone have any idea when our next expected update is due?
thanks zoriden - well explained - isn't INO gonna use IL-12 in there upcoming HPV phase 3?
Isn't one of the criteria for getting phase 3 approval being able to trump the leading drug for that aliment. If so is it possible that we will not trump INO and what it is doing? Also I assume we need to focus on ailments that INO is not involved in
I would love to paste the report but it's not fair on the others. Trust me it was impressive they grow patients T cells and amend them to hunt the cancer all patients are in 100% remission on phase 2. No signs of tumours their technology can be tweaked for all cancers. It's a platform and it's personalised and it's immunotherapy. Either way it's working sure INO has not had 100% remission. Personal email me and I'll share the report
think INO has some serious competition - Patrick Cox replacement has written a glowing article about KITE Pharma (KITE) - looks like they a well ahead of INO - prety much all their patients that have been treated in trials are in remission. low float 19 milion MC 1.2 bill 200 mil in cash
anyone on this board aware of KITE?
i will take one for the team and donate my home brewing kit to INO. hasn't been used since my university days - craned out some disgusting home brew in my time - never the same it still got drunk
is that all 10k vaccines a month. i thought we could mass produce. that doesn't sound to me like mass production.
Be nice to see if they are generating some good revenues from their south american lifeline skin drive? wonder if its a bit premature to see this in their bottom line.
So - what is happening - i really hope we have some contracts signed up and revenue generation is off the ground - low burn rate and operating costs could mean this bad boy could be cahs flow positive pretty quickly - i wonder how the health care marketing drive has been going? Either way mgmt have not given any significant updates to gauge - god i hate perserverance GLTA
what happened with British Public health - PHE - did they actually test anything? Anyone have any idea?
Mullens is moving far to slow for my liking. They still have not defined any targets - this is completely rediculous - the pace of development is painfully slow if not defunct. How long does it take to decide a target? Scientists are the worst people to run a company. They should be in the lab not in the board agreeing and pushing deliverables. The stock is stuffed we have no cash we are tied up in legal cases, dilution is the only funding option now. massive naked short position, about to get delisted This goose is cooked. I could strangle Patrick Cox.
just back after 2 weeks - stock chart looks terrible - have mgmt actually pulled finger and come up with a plan of attack yet - or are they still calling meetings to arrange a meeting to decide.
Go with crohns - its is so effectiveas a treatment -helped my sister conrol inflammation. why does it take so long - this company will be well bankrupt before these guys actually get it all together. Scientists are never great at managing deliverables and pushing things through on a timely basis.
INO - should use the ebola pandemic as a launch pad to demonstrate how superior its platform is. They are desperate to try anything. If our platform claims to be able to mass produce bulk vaccines in a short time frame then thats exactly what we should be doing not engaging in phase 1 trials. No other company has the capacity to create bulk quanities of vaccines in an emergency situation
also Inovio's flu vaccine will be far closer to market based on the rate at which NNVC is moving and they have a massive pipeline. Agree that there is a market for both preventative vaccines. But based on this pace of progress they are clearly out of their depth in having mgmt with a track record of delivery. I'm OUT - far to slow - good luck to all. I hope it comes off for you all
mgmt are clearly not being open and honest about their struggling attempts to create bulk flucides for tox studies. Not sure i want to be involved with this company anymore - trasparency is key and the lack of updates regarding delays is completely a valid reason to start questioning the science of the products.
Agree all development companies experience teething issues but not acknowledging them and ignoring your shareholders does smell of something more significant
1million shares is worth 90k - hardly a issue wouldn't you think